View ValuationCinkarna Celje d. d 향후 성장Future 기준 점검 2/6Cinkarna Celje d. d (는) 각각 연간 17.2% 및 2.8% 수익과 수익이 증가할 것으로 예상됩니다.핵심 정보17.2%이익 성장률n/aEPS 성장률Chemicals 이익 성장16.1%매출 성장률2.8%향후 자기자본이익률n/a애널리스트 커버리지Low마지막 업데이트20 May 2026최근 향후 성장 업데이트Price Target Changed • Feb 05Price target decreased by 15% to €30.60Down from €35.80, the current price target is provided by 1 analyst. New target price is 5.8% below last closing price of €32.50. Stock is up 11% over the past year. The company posted earnings per share of €2.97 last year.Price Target Changed • Aug 11Price target increased by 40% to €35.80Up from €25.60, the current price target is provided by 1 analyst. New target price is 8.5% above last closing price of €33.00. Stock is up 39% over the past year. The company is forecast to post earnings per share of €3.20 for next year compared to €2.97 last year.Price Target Changed • May 22Price target decreased by 7.3% to €25.50Down from €27.50, the current price target is provided by 1 analyst. New target price is 29% below last closing price of €35.90. Stock is up 68% over the past year. The company posted earnings per share of €2.97 last year.Price Target Changed • Nov 16Price target increased to €33.10Up from €27.50, the current price target is provided by 1 analyst. New target price is 29% above last closing price of €25.60. Stock is up 1.2% over the past year. The company is forecast to post earnings per share of €4.78 for next year compared to €4.11 last year.모든 업데이트 보기Recent updatesUpcoming Dividend • Jun 19Upcoming dividend of €1.80 per shareEligible shareholders must have bought the stock before 26 June 2026. Payment date: 30 June 2026. Payout ratio is a comfortable 56% but the company is paying out more than the cash it is generating. Trailing yield: 5.6%. Within top quartile of Slovenian dividend payers (4.6%). Higher than average of industry peers (3.2%).Reported Earnings • May 24First quarter 2026 earnings released: EPS: €0.38 (vs €0.78 in 1Q 2025)First quarter 2026 results: EPS: €0.38 (down from €0.78 in 1Q 2025). Revenue: €51.0m (down 14% from 1Q 2025). Net income: €3.05m (down 52% from 1Q 2025). Profit margin: 6.0% (down from 11% in 1Q 2025). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 2.8% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 10% per year.New Risk • May 24New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 8.3% Last year net profit margin: 13% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (128% cash payout ratio). Profit margins are more than 30% lower than last year (8.3% net profit margin).Declared Dividend • Apr 17Dividend of €1.80 announcedDividend of €1.80 is the same as last year. Ex-date: 26th June 2026 Payment date: 30th June 2026 Dividend yield will be 5.7%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is covered by earnings (56% earnings payout ratio) but not covered by cash flows (265% cash payout ratio). The dividend has increased by an average of 16% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 46% over the next 3 years, which should provide support to the dividend and adequate earnings cover.공고 • Apr 17Cinkarna Celje, d. d. announces Annual dividend, payable on June 30, 2026Cinkarna Celje, d. d. announced Annual dividend of EUR 1.8000 per share payable on June 30, 2026, ex-date on June 26, 2026 and record date on June 29, 2026.Reported Earnings • Mar 05Full year 2025 earnings released: EPS: €2.41 (vs €2.97 in FY 2024)Full year 2025 results: EPS: €2.41 (down from €2.97 in FY 2024). Revenue: €203.0m (flat on FY 2024). Net income: €19.5m (down 16% from FY 2024). Profit margin: 9.6% (down from 11% in FY 2024). Revenue is forecast to grow 2.1% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.Price Target Changed • Feb 05Price target decreased by 15% to €30.60Down from €35.80, the current price target is provided by 1 analyst. New target price is 5.8% below last closing price of €32.50. Stock is up 11% over the past year. The company posted earnings per share of €2.97 last year.Reported Earnings • Nov 14Third quarter 2025 earnings released: EPS: €0.50 (vs €0.93 in 3Q 2024)Third quarter 2025 results: EPS: €0.50 (down from €0.93 in 3Q 2024). Revenue: €48.5m (down 10% from 3Q 2024). Net income: €4.06m (down 44% from 3Q 2024). Profit margin: 8.4% (down from 13% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 2.6% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.Reported Earnings • Aug 28Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: €53.8m (flat on 2Q 2024). Net income: €5.94m (down 2.9% from 2Q 2024). Profit margin: 11% (in line with 2Q 2024). Revenue is forecast to grow 1.7% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.Price Target Changed • Aug 11Price target increased by 40% to €35.80Up from €25.60, the current price target is provided by 1 analyst. New target price is 8.5% above last closing price of €33.00. Stock is up 39% over the past year. The company is forecast to post earnings per share of €3.20 for next year compared to €2.97 last year.Upcoming Dividend • Jun 17Upcoming dividend of €1.80 per shareEligible shareholders must have bought the stock before 24 June 2025. Payment date: 27 June 2025. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 12%. Within top quartile of Slovenian dividend payers (4.6%). Higher than average of industry peers (2.6%).Price Target Changed • May 22Price target decreased by 7.3% to €25.50Down from €27.50, the current price target is provided by 1 analyst. New target price is 29% below last closing price of €35.90. Stock is up 68% over the past year. The company posted earnings per share of €2.97 last year.분석 기사 • May 14Here's Why We Think Cinkarna Celje, d. d.'s (LJSE:CICG) CEO Compensation Looks Fair for the time beingKey Insights Cinkarna Celje d. d will host its Annual General Meeting on 21st of May Salary of €306.9k is part of CEO...공고 • Apr 17Cinkarna Celje, d. d., Annual General Meeting, May 21, 2025Cinkarna Celje, d. d., Annual General Meeting, May 21, 2025.분석 기사 • Mar 12We Think Cinkarna Celje d. d's (LJSE:CICG) Robust Earnings Are ConservativeCinkarna Celje, d. d. ( LJSE:CICG ) recently posted some strong earnings, and the market responded positively. Our...Reported Earnings • Mar 06Full year 2024 earnings released: EPS: €2.86 (vs €1.57 in FY 2023)Full year 2024 results: EPS: €2.86 (up from €1.57 in FY 2023). Revenue: €203.7m (up 14% from FY 2023). Net income: €23.1m (up 83% from FY 2023). Profit margin: 11% (up from 7.0% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.Reported Earnings • Dec 01Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: €54.0m (up 34% from 3Q 2023). Net income: €7.22m (up €7.06m from 3Q 2023). Profit margin: 13% (up from 0.4% in 3Q 2023). The increase in margin was driven by higher revenue.분석 기사 • Sep 05Cinkarna Celje d. d's (LJSE:CICG) Conservative Accounting Might Explain Soft EarningsCinkarna Celje, d. d.'s ( LJSE:CICG ) stock was strong despite it releasing a soft earnings report last week. Our...Reported Earnings • Aug 31Second quarter 2024 earnings released: EPS: €0.76 (vs €0.41 in 2Q 2023)Second quarter 2024 results: EPS: €0.76 (up from €0.41 in 2Q 2023). Revenue: €54.1m (up 15% from 2Q 2023). Net income: €6.11m (up 89% from 2Q 2023). Profit margin: 11% (up from 6.9% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has remained flat, which means it is well ahead of earnings.공고 • Jul 31Allianz ZB d.o.o. acquired a 5.32% stake in Cinkarna Celje, d. d. (LJSE:CICG).Allianz ZB d.o.o. acquired a 5.32% stake in Cinkarna Celje, d. d. (LJSE:CICG) on July 29, 2024. Allianz ZB d.o.o. completed the acquisition of a 5.32% stake in Cinkarna Celje, d. d. (LJSE:CICG) on July 29, 2024.공고 • Jul 17Cinkarna Celje, d. d. (LJSE:CICG) commences an Equity Buyback, under the authorization approved on June 19, 2024.Cinkarna Celje, d. d. (LJSE:CICG) commences share repurchases on July 10, 2024, under the program mandated by the shareholders in the Annual General Meeting held on June 19, 2024. As per the mandate, the company is authorized to repurchase its own shares, such that the company’s holding in treasury does not exceed 10% of its issued share capital. The repurchase price will not be lower than €14 per share and not higher than €29 per share. The authorization is valid for a period of 12 months, from the passing of this resolution.Upcoming Dividend • Jun 19Upcoming dividend of €0.90 per shareEligible shareholders must have bought the stock before 26 June 2024. Payment date: 28 June 2024. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 14%. Within top quartile of Slovenian dividend payers (6.5%). Higher than average of industry peers (2.8%).공고 • May 21Cinkarna Celje, d. d., Annual General Meeting, Jun 19, 2024Cinkarna Celje, d. d., Annual General Meeting, Jun 19, 2024, at 15:00 Central European Standard Time.New Risk • May 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Slovenian stocks, typically moving 4.6% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (4.6% average weekly change). Dividend is not well covered by earnings and cash flows. Payout ratio: 204% Cash payout ratio: 315% Minor Risk Profit margins are more than 30% lower than last year (7.0% net profit margin).Reported Earnings • Apr 21Full year 2023 earnings released: EPS: €1.57 (vs €5.37 in FY 2022)Full year 2023 results: EPS: €1.57 (down from €5.37 in FY 2022). Revenue: €179.5m (down 22% from FY 2022). Net income: €12.7m (down 71% from FY 2022). Profit margin: 7.0% (down from 19% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has remained flat.Reported Earnings • Mar 07Full year 2023 earnings released: EPS: €0.70 (vs €5.55 in FY 2022)Full year 2023 results: EPS: €0.70 (down from €5.55 in FY 2022). Revenue: €179.5m (down 22% from FY 2022). Net income: €5.49m (down 87% from FY 2022). Profit margin: 3.1% (down from 19% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has remained flat, which means it is well ahead of earnings.분석 기사 • Feb 22The Returns On Capital At Cinkarna Celje d. d (LJSE:CICG) Don't Inspire ConfidenceWhat underlying fundamental trends can indicate that a company might be in decline? Typically, we'll see the trend of...Upcoming Dividend • Feb 14Upcoming dividend of €2.77 per share at 11% yieldEligible shareholders must have bought the stock before 21 February 2024. Payment date: 23 February 2024. Trailing yield: 11%. Within top quartile of Slovenian dividend payers (7.1%). Higher than average of industry peers (3.1%).Valuation Update With 7 Day Price Move • Jan 08Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €23.90, the stock trades at a trailing P/E ratio of 16.9x. Average trailing P/E is 13x in the Chemicals industry in Europe. Total returns to shareholders of 60% over the past three years.Reported Earnings • Dec 01Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: €40.3m (down 27% from 3Q 2022). Net income: €163.6k (down 98% from 3Q 2022). Profit margin: 0.4% (down from 17% in 3Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.New Risk • Nov 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Slovenian stocks, typically moving 2.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 107% Cash payout ratio: 112% Minor Risks Share price has been volatile over the past 3 months (2.8% average weekly change). Profit margins are more than 30% lower than last year (11% net profit margin).New Risk • Sep 01New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 11% Last year net profit margin: 21% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (112% cash payout ratio). Profit margins are more than 30% lower than last year (11% net profit margin).Buying Opportunity • Apr 19Now 26% undervaluedOver the last 90 days, the stock is up 10.0%. The fair value is estimated to be €37.33, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 39%.분석 기사 • Mar 16We Think That There Are Issues Underlying Cinkarna Celje d. d's (LJSE:CICG) EarningsCinkarna Celje, d. d.'s ( LJSE:CICG ) robust earnings report didn't manage to move the market for its stock. Our...Reported Earnings • Mar 09Full year 2022 earnings released: EPS: €5.41 (vs €4.11 in FY 2021)Full year 2022 results: EPS: €5.41 (up from €4.11 in FY 2021). Revenue: €229.6m (up 17% from FY 2021). Net income: €42.3m (up 27% from FY 2021). Profit margin: 18% (up from 17% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has only increased by 27% per year, which means it is significantly lagging earnings growth.Reported Earnings • Dec 02Third quarter 2022 earnings released: EPS: €1.21 (vs €1.32 in 3Q 2021)Third quarter 2022 results: EPS: €1.21 (down from €1.32 in 3Q 2021). Revenue: €54.9m (up 16% from 3Q 2021). Net income: €9.46m (down 8.5% from 3Q 2021). Profit margin: 17% (down from 22% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.Price Target Changed • Nov 16Price target increased to €33.10Up from €27.50, the current price target is provided by 1 analyst. New target price is 29% above last closing price of €25.60. Stock is up 1.2% over the past year. The company is forecast to post earnings per share of €4.78 for next year compared to €4.11 last year.Reported Earnings • Sep 04Second quarter 2022 earnings released: EPS: €1.86 (vs €1.07 in 2Q 2021)Second quarter 2022 results: EPS: €1.86 (up from €1.07 in 2Q 2021). Revenue: €68.6m (up 38% from 2Q 2021). Net income: €14.5m (up 73% from 2Q 2021). Profit margin: 21% (up from 17% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 12% compared to a 14% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.Buying Opportunity • Aug 16Now 76% undervalued after recent price dropOver the last 90 days, the stock is down 90%. The fair value is estimated to be €119, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last 3 years. Earnings per share has grown by 26%. For the next 3 years, revenue is forecast to grow by 2.4% per annum. Earnings is also forecast to grow by 0.4% per annum over the same time period.분석 기사 • Jun 17Cinkarna Celje d. d (LJSE:CICG) Will Pay A Larger Dividend Than Last Year At €31.89The board of Cinkarna Celje, d. d. ( LJSE:CICG ) has announced that it will be increasing its dividend by 52% on the...Upcoming Dividend • Jun 15Upcoming dividend of €21.00 per shareEligible shareholders must have bought the stock before 22 June 2022. Payment date: 24 June 2022. Payout ratio is a comfortable 40% and this is well supported by cash flows. Trailing yield: 6.8%. Lower than top quartile of Slovenian dividend payers (6.9%). Higher than average of industry peers (3.7%).Reported Earnings • May 15First quarter 2022 earnings released: EPS: €19.93 (vs €9.49 in 1Q 2021)First quarter 2022 results: EPS: €19.93 (up from €9.49 in 1Q 2021). Revenue: €66.9m (up 31% from 1Q 2021). Net income: €15.6m (up 110% from 1Q 2021). Profit margin: 23% (up from 14% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.Reported Earnings • Mar 10Full year 2021 earnings: EPS in line with expectations, revenues disappointFull year 2021 results: EPS: €41.12 (up from €23.45 in FY 2020). Revenue: €196.2m (up 11% from FY 2020). Net income: €33.2m (up 75% from FY 2020). Profit margin: 17% (up from 11% in FY 2020). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 1.8%. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 5% per year.Reported Earnings • Nov 27Third quarter 2021 earnings: EPS in line with expectations, revenues disappointThird quarter 2021 results: EPS: €12.80 (up from €4.77 in 3Q 2020). Revenue: €47.9m (up 12% from 3Q 2020). Net income: €10.3m (up 168% from 3Q 2020). Profit margin: 22% (up from 9.0% in 3Q 2020). The increase in margin was primarily driven by higher revenue. Revenue missed analyst estimates by 1.8%. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.Reported Earnings • Sep 03Second quarter 2021 earnings released: EPS €10.38 (vs €3.80 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €50.4m (up 21% from 2Q 2020). Net income: €8.39m (up 177% from 2Q 2020). Profit margin: 17% (up from 7.3% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.공고 • Aug 08Cinkarna Celje, d. d. (LJSE:CICG) commences an Equity Buyback Plan for 80,797 shares, representing 10% of its issued share capital, under the authorization approved on June 15, 2021.Cinkarna Celje, d. d. (LJSE:CICG) commences share repurchases on August 3, 2021, under the program mandated by the shareholders in the Annual General Meeting held on June 15, 2021. As per the mandate, the company is authorized to repurchase up to 80,797 shares, representing 10% of its issued share capital. The repurchase price will not be lower than €120 per share and not higher than €270 per share. The company will finance the buyback of treasury shares from the surplus of liquid assets from own resources. The authorization is valid for a period of 12 months, until June 18, 2021. As of June 15, 2021, the company had 25,315 shares in treasury.Upcoming Dividend • Jun 16Upcoming dividend of €17.00 per shareEligible shareholders must have bought the stock before 22 June 2021. Payment date: 24 June 2021. Trailing yield: 4.6%. Lower than top quartile of Slovenian dividend payers (6.3%). Higher than average of industry peers (2.3%).Reported Earnings • May 16First quarter 2021 earnings releasedThe company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2021 results: Revenue: €51.8m (up 5.9% from 1Q 2020). Net income: €7.44m (up 7.9% from 1Q 2020). Profit margin: 14% (in line with 1Q 2020).분석 기사 • May 03Three Things You Should Check Before Buying Cinkarna Celje, d. d. (LJSE:CICG) For Its DividendDividend paying stocks like Cinkarna Celje, d. d. ( LJSE:CICG ) tend to be popular with investors, and for good reason...분석 기사 • Mar 15Did You Participate In Any Of Cinkarna Celje d. d's (LJSE:CICG) Incredible 307% Return?When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...Is New 90 Day High Low • Feb 24New 90-day high: €200The company is up 16% from its price of €172 on 26 November 2020. The Slovenian market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period.분석 기사 • Feb 18Is Cinkarna Celje, d. d. (LJSE:CICG) Popular Amongst Institutions?Every investor in Cinkarna Celje, d. d. ( LJSE:CICG ) should be aware of the most powerful shareholder groups...Is New 90 Day High Low • Feb 04New 90-day high: €191The company is up 19% from its price of €160 on 06 November 2020. The Slovenian market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period.분석 기사 • Jan 25What Do The Returns At Cinkarna Celje d. d (LJSE:CICG) Mean Going Forward?If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Is New 90 Day High Low • Jan 08New 90-day high: €183The company is up 12% from its price of €163 on 08 October 2020. The Slovenian market is also up 12% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it outperformed the Chemicals industry, which is up 7.0% over the same period.분석 기사 • Dec 31Is Cinkarna Celje, d. d. (LJSE:CICG) At Risk Of Cutting Its Dividend?Could Cinkarna Celje, d. d. ( LJSE:CICG ) be an attractive dividend share to own for the long haul? Investors are often...분석 기사 • Dec 11Are Robust Financials Driving The Recent Rally In Cinkarna Celje, d. d.'s (LJSE:CICG) Stock?Cinkarna Celje d. d (LJSE:CICG) has had a great run on the share market with its stock up by a significant 13% over the...Is New 90 Day High Low • Nov 26New 90-day high: €170The company is up 3.0% from its price of €165 on 28 August 2020. The Slovenian market is also up 3.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 4.0% over the same period.분석 기사 • Nov 19Calculating The Fair Value Of Cinkarna Celje, d. d. (LJSE:CICG)Does the November share price for Cinkarna Celje, d. d. (LJSE:CICG) reflect what it's really worth? Today, we will...Is New 90 Day High Low • Oct 29New 90-day low: €153The company is down 4.0% from its price of €160 on 30 July 2020. The Slovenian market is also down 4.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 1.0% over the same period.이익 및 매출 성장 예측LJSE:CICG - 애널리스트 향후 추정치 및 과거 재무 데이터 (EUR Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/2028211242541112/31/2027202161832112/31/2026194911713/31/2026195161128N/A12/31/202520319525N/A9/30/2025208251330N/A6/30/2025214281430N/A3/31/2025214282844N/A12/31/2024204234256N/A9/30/2024198203454N/A6/30/2024184133050N/A3/31/2024177101333N/A12/31/202317913828N/A9/30/202317711-112N/A6/30/2023192201931N/A3/31/2023213321223N/A12/31/2022230431021N/A9/30/2022238473749N/A6/30/2022231473041N/A3/31/2022212413849N/A12/31/2021196333951N/A9/30/2021191312535N/A6/30/2021187252737N/A3/31/2021179193344N/A12/31/2020176192133N/A9/30/202017216N/AN/AN/A6/30/2020172191124N/A3/31/202017824N/AN/AN/A12/31/201917521N/A34N/A9/30/201916821N/AN/AN/A6/30/201916220N/A35N/A3/31/201916022N/AN/AN/A12/31/201816731N/A34N/A9/30/201818231N/AN/AN/A6/30/201819638N/A49N/A3/31/201819935N/AN/AN/A12/31/201719129N/A36N/A9/30/201718426N/AN/AN/A6/30/201717819N/A33N/A3/31/201717616N/AN/AN/A12/31/201617210N/A29N/A9/30/201617010N/AN/AN/A6/30/20161677N/A10N/A3/31/20161686N/AN/AN/A12/31/20151717N/A13N/A9/30/20151688N/AN/AN/A더 보기애널리스트 향후 성장 전망수입 대 저축률: CICG 의 연간 예상 수익 증가율(17.2%)이 saving rate(2.6%)보다 높습니다.수익 vs 시장: CICG 의 연간 수익(17.2%)이 SI 시장(6.7%)보다 빠르게 성장할 것으로 예상됩니다.고성장 수익: CICG 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: CICG 의 수익(연간 2.8%)이 SI 시장(연간 5.2%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: CICG 의 수익(연간 2.8%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: CICG의 자본 수익률이 3년 후 높을 것으로 예상되는지 판단하기에 데이터가 부족합니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/19 08:52종가2026/07/17 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Cinkarna Celje, d. d.는 2명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Tea PevecInterCapital Securities Ltd.Vladan PavlovicIpopema Securities S.A.
Price Target Changed • Feb 05Price target decreased by 15% to €30.60Down from €35.80, the current price target is provided by 1 analyst. New target price is 5.8% below last closing price of €32.50. Stock is up 11% over the past year. The company posted earnings per share of €2.97 last year.
Price Target Changed • Aug 11Price target increased by 40% to €35.80Up from €25.60, the current price target is provided by 1 analyst. New target price is 8.5% above last closing price of €33.00. Stock is up 39% over the past year. The company is forecast to post earnings per share of €3.20 for next year compared to €2.97 last year.
Price Target Changed • May 22Price target decreased by 7.3% to €25.50Down from €27.50, the current price target is provided by 1 analyst. New target price is 29% below last closing price of €35.90. Stock is up 68% over the past year. The company posted earnings per share of €2.97 last year.
Price Target Changed • Nov 16Price target increased to €33.10Up from €27.50, the current price target is provided by 1 analyst. New target price is 29% above last closing price of €25.60. Stock is up 1.2% over the past year. The company is forecast to post earnings per share of €4.78 for next year compared to €4.11 last year.
Upcoming Dividend • Jun 19Upcoming dividend of €1.80 per shareEligible shareholders must have bought the stock before 26 June 2026. Payment date: 30 June 2026. Payout ratio is a comfortable 56% but the company is paying out more than the cash it is generating. Trailing yield: 5.6%. Within top quartile of Slovenian dividend payers (4.6%). Higher than average of industry peers (3.2%).
Reported Earnings • May 24First quarter 2026 earnings released: EPS: €0.38 (vs €0.78 in 1Q 2025)First quarter 2026 results: EPS: €0.38 (down from €0.78 in 1Q 2025). Revenue: €51.0m (down 14% from 1Q 2025). Net income: €3.05m (down 52% from 1Q 2025). Profit margin: 6.0% (down from 11% in 1Q 2025). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 2.8% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 10% per year.
New Risk • May 24New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 8.3% Last year net profit margin: 13% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (128% cash payout ratio). Profit margins are more than 30% lower than last year (8.3% net profit margin).
Declared Dividend • Apr 17Dividend of €1.80 announcedDividend of €1.80 is the same as last year. Ex-date: 26th June 2026 Payment date: 30th June 2026 Dividend yield will be 5.7%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is covered by earnings (56% earnings payout ratio) but not covered by cash flows (265% cash payout ratio). The dividend has increased by an average of 16% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 46% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
공고 • Apr 17Cinkarna Celje, d. d. announces Annual dividend, payable on June 30, 2026Cinkarna Celje, d. d. announced Annual dividend of EUR 1.8000 per share payable on June 30, 2026, ex-date on June 26, 2026 and record date on June 29, 2026.
Reported Earnings • Mar 05Full year 2025 earnings released: EPS: €2.41 (vs €2.97 in FY 2024)Full year 2025 results: EPS: €2.41 (down from €2.97 in FY 2024). Revenue: €203.0m (flat on FY 2024). Net income: €19.5m (down 16% from FY 2024). Profit margin: 9.6% (down from 11% in FY 2024). Revenue is forecast to grow 2.1% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
Price Target Changed • Feb 05Price target decreased by 15% to €30.60Down from €35.80, the current price target is provided by 1 analyst. New target price is 5.8% below last closing price of €32.50. Stock is up 11% over the past year. The company posted earnings per share of €2.97 last year.
Reported Earnings • Nov 14Third quarter 2025 earnings released: EPS: €0.50 (vs €0.93 in 3Q 2024)Third quarter 2025 results: EPS: €0.50 (down from €0.93 in 3Q 2024). Revenue: €48.5m (down 10% from 3Q 2024). Net income: €4.06m (down 44% from 3Q 2024). Profit margin: 8.4% (down from 13% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 2.6% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.
Reported Earnings • Aug 28Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: €53.8m (flat on 2Q 2024). Net income: €5.94m (down 2.9% from 2Q 2024). Profit margin: 11% (in line with 2Q 2024). Revenue is forecast to grow 1.7% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.
Price Target Changed • Aug 11Price target increased by 40% to €35.80Up from €25.60, the current price target is provided by 1 analyst. New target price is 8.5% above last closing price of €33.00. Stock is up 39% over the past year. The company is forecast to post earnings per share of €3.20 for next year compared to €2.97 last year.
Upcoming Dividend • Jun 17Upcoming dividend of €1.80 per shareEligible shareholders must have bought the stock before 24 June 2025. Payment date: 27 June 2025. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 12%. Within top quartile of Slovenian dividend payers (4.6%). Higher than average of industry peers (2.6%).
Price Target Changed • May 22Price target decreased by 7.3% to €25.50Down from €27.50, the current price target is provided by 1 analyst. New target price is 29% below last closing price of €35.90. Stock is up 68% over the past year. The company posted earnings per share of €2.97 last year.
분석 기사 • May 14Here's Why We Think Cinkarna Celje, d. d.'s (LJSE:CICG) CEO Compensation Looks Fair for the time beingKey Insights Cinkarna Celje d. d will host its Annual General Meeting on 21st of May Salary of €306.9k is part of CEO...
공고 • Apr 17Cinkarna Celje, d. d., Annual General Meeting, May 21, 2025Cinkarna Celje, d. d., Annual General Meeting, May 21, 2025.
분석 기사 • Mar 12We Think Cinkarna Celje d. d's (LJSE:CICG) Robust Earnings Are ConservativeCinkarna Celje, d. d. ( LJSE:CICG ) recently posted some strong earnings, and the market responded positively. Our...
Reported Earnings • Mar 06Full year 2024 earnings released: EPS: €2.86 (vs €1.57 in FY 2023)Full year 2024 results: EPS: €2.86 (up from €1.57 in FY 2023). Revenue: €203.7m (up 14% from FY 2023). Net income: €23.1m (up 83% from FY 2023). Profit margin: 11% (up from 7.0% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.
Reported Earnings • Dec 01Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: €54.0m (up 34% from 3Q 2023). Net income: €7.22m (up €7.06m from 3Q 2023). Profit margin: 13% (up from 0.4% in 3Q 2023). The increase in margin was driven by higher revenue.
분석 기사 • Sep 05Cinkarna Celje d. d's (LJSE:CICG) Conservative Accounting Might Explain Soft EarningsCinkarna Celje, d. d.'s ( LJSE:CICG ) stock was strong despite it releasing a soft earnings report last week. Our...
Reported Earnings • Aug 31Second quarter 2024 earnings released: EPS: €0.76 (vs €0.41 in 2Q 2023)Second quarter 2024 results: EPS: €0.76 (up from €0.41 in 2Q 2023). Revenue: €54.1m (up 15% from 2Q 2023). Net income: €6.11m (up 89% from 2Q 2023). Profit margin: 11% (up from 6.9% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
공고 • Jul 31Allianz ZB d.o.o. acquired a 5.32% stake in Cinkarna Celje, d. d. (LJSE:CICG).Allianz ZB d.o.o. acquired a 5.32% stake in Cinkarna Celje, d. d. (LJSE:CICG) on July 29, 2024. Allianz ZB d.o.o. completed the acquisition of a 5.32% stake in Cinkarna Celje, d. d. (LJSE:CICG) on July 29, 2024.
공고 • Jul 17Cinkarna Celje, d. d. (LJSE:CICG) commences an Equity Buyback, under the authorization approved on June 19, 2024.Cinkarna Celje, d. d. (LJSE:CICG) commences share repurchases on July 10, 2024, under the program mandated by the shareholders in the Annual General Meeting held on June 19, 2024. As per the mandate, the company is authorized to repurchase its own shares, such that the company’s holding in treasury does not exceed 10% of its issued share capital. The repurchase price will not be lower than €14 per share and not higher than €29 per share. The authorization is valid for a period of 12 months, from the passing of this resolution.
Upcoming Dividend • Jun 19Upcoming dividend of €0.90 per shareEligible shareholders must have bought the stock before 26 June 2024. Payment date: 28 June 2024. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 14%. Within top quartile of Slovenian dividend payers (6.5%). Higher than average of industry peers (2.8%).
공고 • May 21Cinkarna Celje, d. d., Annual General Meeting, Jun 19, 2024Cinkarna Celje, d. d., Annual General Meeting, Jun 19, 2024, at 15:00 Central European Standard Time.
New Risk • May 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Slovenian stocks, typically moving 4.6% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (4.6% average weekly change). Dividend is not well covered by earnings and cash flows. Payout ratio: 204% Cash payout ratio: 315% Minor Risk Profit margins are more than 30% lower than last year (7.0% net profit margin).
Reported Earnings • Apr 21Full year 2023 earnings released: EPS: €1.57 (vs €5.37 in FY 2022)Full year 2023 results: EPS: €1.57 (down from €5.37 in FY 2022). Revenue: €179.5m (down 22% from FY 2022). Net income: €12.7m (down 71% from FY 2022). Profit margin: 7.0% (down from 19% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has remained flat.
Reported Earnings • Mar 07Full year 2023 earnings released: EPS: €0.70 (vs €5.55 in FY 2022)Full year 2023 results: EPS: €0.70 (down from €5.55 in FY 2022). Revenue: €179.5m (down 22% from FY 2022). Net income: €5.49m (down 87% from FY 2022). Profit margin: 3.1% (down from 19% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
분석 기사 • Feb 22The Returns On Capital At Cinkarna Celje d. d (LJSE:CICG) Don't Inspire ConfidenceWhat underlying fundamental trends can indicate that a company might be in decline? Typically, we'll see the trend of...
Upcoming Dividend • Feb 14Upcoming dividend of €2.77 per share at 11% yieldEligible shareholders must have bought the stock before 21 February 2024. Payment date: 23 February 2024. Trailing yield: 11%. Within top quartile of Slovenian dividend payers (7.1%). Higher than average of industry peers (3.1%).
Valuation Update With 7 Day Price Move • Jan 08Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €23.90, the stock trades at a trailing P/E ratio of 16.9x. Average trailing P/E is 13x in the Chemicals industry in Europe. Total returns to shareholders of 60% over the past three years.
Reported Earnings • Dec 01Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: €40.3m (down 27% from 3Q 2022). Net income: €163.6k (down 98% from 3Q 2022). Profit margin: 0.4% (down from 17% in 3Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
New Risk • Nov 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Slovenian stocks, typically moving 2.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 107% Cash payout ratio: 112% Minor Risks Share price has been volatile over the past 3 months (2.8% average weekly change). Profit margins are more than 30% lower than last year (11% net profit margin).
New Risk • Sep 01New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 11% Last year net profit margin: 21% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (112% cash payout ratio). Profit margins are more than 30% lower than last year (11% net profit margin).
Buying Opportunity • Apr 19Now 26% undervaluedOver the last 90 days, the stock is up 10.0%. The fair value is estimated to be €37.33, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 39%.
분석 기사 • Mar 16We Think That There Are Issues Underlying Cinkarna Celje d. d's (LJSE:CICG) EarningsCinkarna Celje, d. d.'s ( LJSE:CICG ) robust earnings report didn't manage to move the market for its stock. Our...
Reported Earnings • Mar 09Full year 2022 earnings released: EPS: €5.41 (vs €4.11 in FY 2021)Full year 2022 results: EPS: €5.41 (up from €4.11 in FY 2021). Revenue: €229.6m (up 17% from FY 2021). Net income: €42.3m (up 27% from FY 2021). Profit margin: 18% (up from 17% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has only increased by 27% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Dec 02Third quarter 2022 earnings released: EPS: €1.21 (vs €1.32 in 3Q 2021)Third quarter 2022 results: EPS: €1.21 (down from €1.32 in 3Q 2021). Revenue: €54.9m (up 16% from 3Q 2021). Net income: €9.46m (down 8.5% from 3Q 2021). Profit margin: 17% (down from 22% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.
Price Target Changed • Nov 16Price target increased to €33.10Up from €27.50, the current price target is provided by 1 analyst. New target price is 29% above last closing price of €25.60. Stock is up 1.2% over the past year. The company is forecast to post earnings per share of €4.78 for next year compared to €4.11 last year.
Reported Earnings • Sep 04Second quarter 2022 earnings released: EPS: €1.86 (vs €1.07 in 2Q 2021)Second quarter 2022 results: EPS: €1.86 (up from €1.07 in 2Q 2021). Revenue: €68.6m (up 38% from 2Q 2021). Net income: €14.5m (up 73% from 2Q 2021). Profit margin: 21% (up from 17% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 12% compared to a 14% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.
Buying Opportunity • Aug 16Now 76% undervalued after recent price dropOver the last 90 days, the stock is down 90%. The fair value is estimated to be €119, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last 3 years. Earnings per share has grown by 26%. For the next 3 years, revenue is forecast to grow by 2.4% per annum. Earnings is also forecast to grow by 0.4% per annum over the same time period.
분석 기사 • Jun 17Cinkarna Celje d. d (LJSE:CICG) Will Pay A Larger Dividend Than Last Year At €31.89The board of Cinkarna Celje, d. d. ( LJSE:CICG ) has announced that it will be increasing its dividend by 52% on the...
Upcoming Dividend • Jun 15Upcoming dividend of €21.00 per shareEligible shareholders must have bought the stock before 22 June 2022. Payment date: 24 June 2022. Payout ratio is a comfortable 40% and this is well supported by cash flows. Trailing yield: 6.8%. Lower than top quartile of Slovenian dividend payers (6.9%). Higher than average of industry peers (3.7%).
Reported Earnings • May 15First quarter 2022 earnings released: EPS: €19.93 (vs €9.49 in 1Q 2021)First quarter 2022 results: EPS: €19.93 (up from €9.49 in 1Q 2021). Revenue: €66.9m (up 31% from 1Q 2021). Net income: €15.6m (up 110% from 1Q 2021). Profit margin: 23% (up from 14% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Mar 10Full year 2021 earnings: EPS in line with expectations, revenues disappointFull year 2021 results: EPS: €41.12 (up from €23.45 in FY 2020). Revenue: €196.2m (up 11% from FY 2020). Net income: €33.2m (up 75% from FY 2020). Profit margin: 17% (up from 11% in FY 2020). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 1.8%. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 5% per year.
Reported Earnings • Nov 27Third quarter 2021 earnings: EPS in line with expectations, revenues disappointThird quarter 2021 results: EPS: €12.80 (up from €4.77 in 3Q 2020). Revenue: €47.9m (up 12% from 3Q 2020). Net income: €10.3m (up 168% from 3Q 2020). Profit margin: 22% (up from 9.0% in 3Q 2020). The increase in margin was primarily driven by higher revenue. Revenue missed analyst estimates by 1.8%. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.
Reported Earnings • Sep 03Second quarter 2021 earnings released: EPS €10.38 (vs €3.80 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €50.4m (up 21% from 2Q 2020). Net income: €8.39m (up 177% from 2Q 2020). Profit margin: 17% (up from 7.3% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
공고 • Aug 08Cinkarna Celje, d. d. (LJSE:CICG) commences an Equity Buyback Plan for 80,797 shares, representing 10% of its issued share capital, under the authorization approved on June 15, 2021.Cinkarna Celje, d. d. (LJSE:CICG) commences share repurchases on August 3, 2021, under the program mandated by the shareholders in the Annual General Meeting held on June 15, 2021. As per the mandate, the company is authorized to repurchase up to 80,797 shares, representing 10% of its issued share capital. The repurchase price will not be lower than €120 per share and not higher than €270 per share. The company will finance the buyback of treasury shares from the surplus of liquid assets from own resources. The authorization is valid for a period of 12 months, until June 18, 2021. As of June 15, 2021, the company had 25,315 shares in treasury.
Upcoming Dividend • Jun 16Upcoming dividend of €17.00 per shareEligible shareholders must have bought the stock before 22 June 2021. Payment date: 24 June 2021. Trailing yield: 4.6%. Lower than top quartile of Slovenian dividend payers (6.3%). Higher than average of industry peers (2.3%).
Reported Earnings • May 16First quarter 2021 earnings releasedThe company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2021 results: Revenue: €51.8m (up 5.9% from 1Q 2020). Net income: €7.44m (up 7.9% from 1Q 2020). Profit margin: 14% (in line with 1Q 2020).
분석 기사 • May 03Three Things You Should Check Before Buying Cinkarna Celje, d. d. (LJSE:CICG) For Its DividendDividend paying stocks like Cinkarna Celje, d. d. ( LJSE:CICG ) tend to be popular with investors, and for good reason...
분석 기사 • Mar 15Did You Participate In Any Of Cinkarna Celje d. d's (LJSE:CICG) Incredible 307% Return?When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...
Is New 90 Day High Low • Feb 24New 90-day high: €200The company is up 16% from its price of €172 on 26 November 2020. The Slovenian market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period.
분석 기사 • Feb 18Is Cinkarna Celje, d. d. (LJSE:CICG) Popular Amongst Institutions?Every investor in Cinkarna Celje, d. d. ( LJSE:CICG ) should be aware of the most powerful shareholder groups...
Is New 90 Day High Low • Feb 04New 90-day high: €191The company is up 19% from its price of €160 on 06 November 2020. The Slovenian market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period.
분석 기사 • Jan 25What Do The Returns At Cinkarna Celje d. d (LJSE:CICG) Mean Going Forward?If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Is New 90 Day High Low • Jan 08New 90-day high: €183The company is up 12% from its price of €163 on 08 October 2020. The Slovenian market is also up 12% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it outperformed the Chemicals industry, which is up 7.0% over the same period.
분석 기사 • Dec 31Is Cinkarna Celje, d. d. (LJSE:CICG) At Risk Of Cutting Its Dividend?Could Cinkarna Celje, d. d. ( LJSE:CICG ) be an attractive dividend share to own for the long haul? Investors are often...
분석 기사 • Dec 11Are Robust Financials Driving The Recent Rally In Cinkarna Celje, d. d.'s (LJSE:CICG) Stock?Cinkarna Celje d. d (LJSE:CICG) has had a great run on the share market with its stock up by a significant 13% over the...
Is New 90 Day High Low • Nov 26New 90-day high: €170The company is up 3.0% from its price of €165 on 28 August 2020. The Slovenian market is also up 3.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 4.0% over the same period.
분석 기사 • Nov 19Calculating The Fair Value Of Cinkarna Celje, d. d. (LJSE:CICG)Does the November share price for Cinkarna Celje, d. d. (LJSE:CICG) reflect what it's really worth? Today, we will...
Is New 90 Day High Low • Oct 29New 90-day low: €153The company is down 4.0% from its price of €160 on 30 July 2020. The Slovenian market is also down 4.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 1.0% over the same period.